Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Scholar Rock Holding Corporation - Common Stock
(NQ:
SRRK
)
34.55
-1.24 (-3.46%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 13, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Scholar Rock Holding Corporation - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stocks That Hit 52-Week Lows On Friday
January 14, 2022
During Friday's session, 445 companies made new 52-week lows. Noteable 52-Week Lows: Intuitive Surgical (NASDAQ:ISRG) is the largest company in terms of market cap to...
Via
Benzinga
Scholar Rock Provides Corporate Update and Highlights Priorities for 2022
January 10, 2022
From
Scholar Rock
Via
Business Wire
Scholar Rock to Present at the 40th Annual J.P. Morgan Healthcare Conference
January 04, 2022
From
Scholar Rock
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
December 22, 2021
Gainers BiondVax Pharmaceuticals (NASDAQ:BVXV...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 22, 2021
December 22, 2021
Upgrades According to Loop Capital, the prior rating for Williams-Sonoma Inc (NYSE:
Via
Benzinga
Scholar Rock Outlines Pivotal Apitegromab Trial Design In Spinal Muscular Atrophy Patients
December 01, 2021
Scholar Rock Holding Corp (NASDAQ: SRRK) announced the study design for the SAPPHIRE Phase 3 trial of apitegromab, a selective inhibitor of the activation of latent...
Via
Benzinga
Scholar Rock Announces Design of Phase 3 SAPPHIRE Clinical Trial Evaluating Apitegromab in Non-Ambulatory Patients with Type 2 and Type 3 Spinal Muscular Atrophy (SMA)
November 30, 2021
From
Scholar Rock
Via
Business Wire
Scholar Rock Presents Data from Part A of the DRAGON Phase 1 Trial Evaluating SRK-181 as Monotherapy and in Combination with Anti-PD-(L)1 for the Treatment of Solid Tumors -- Announces Advancement into Part B
November 12, 2021
From
Scholar Rock
Via
Business Wire
48 Stocks Moving In Friday's Mid-Day Session
November 26, 2021
Gainers Allied Healthcare Products, Inc. (NASDAQ: AHPI) shares jumped 68% to $9.04. Shares of mask and protective apparel companies, including Allied Healthcare Products, traded...
Via
Benzinga
Scholar Rock Reports Third Quarter 2021 Financial Results and Highlights Business Progress
November 09, 2021
From
Scholar Rock
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For November 19, 2021
November 19, 2021
Upgrades Morgan Stanley upgraded the previous rating for EQT Corp (NYSE:
Via
Benzinga
Scholar Rock to Present at Upcoming Healthcare Conferences
November 02, 2021
From
Scholar Rock
Via
Business Wire
Scholar Rock to Present Apitegromab TOPAZ Phase 2 Pharmacologic Data at the 2021 World Congress of Neurology
October 03, 2021
From
Scholar Rock
Via
Business Wire
Scholar Rock Presents Exploratory Responder Analysis on Efficacy Data from the Apitegromab TOPAZ Phase 2 Trial at the Child Neurology Society Annual Meeting
September 30, 2021
From
Scholar Rock
Via
Business Wire
The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug
September 29, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks...
Via
Benzinga
Exposures
Product Safety
Scholar Rock Announces Issuance of U.S. Patent Protecting SRK-181, an Inhibitor of TGFβ1 Activation
September 28, 2021
From
Scholar Rock
Via
Business Wire
Scholar Rock Presents Additional Data Analyses from the Apitegromab TOPAZ Phase 2 Trial at the World Muscle Society 2021 Virtual Congress
September 23, 2021
From
Scholar Rock
Via
Business Wire
Scholar Rock to Present at the 2021 Cantor Virtual Global Healthcare Conference
September 22, 2021
From
Scholar Rock
Via
Business Wire
48 Biggest Movers From Yesterday
September 21, 2021
Gainers Edesa Biotech, Inc. (NASDAQ: EDSA) shares climbed 102.7% to settle at $11.92 on Monday after the company disclosed Phase 2 data of its monoclonal antibody in hospitalized...
Via
Benzinga
Scholar Rock Appoints Caryn Parlavecchio as Chief Human Resources Officer
August 16, 2021
From
Scholar Rock
Via
Business Wire
Scholar Rock Reports Second Quarter 2021 Financial Results and Highlights Business Progress
August 10, 2021
From
Scholar Rock
Via
Business Wire
Scholar Rock to Present at the 2021 Wedbush PacGrow Healthcare Conference
August 05, 2021
From
Scholar Rock
Via
Business Wire
99 Biggest Movers From Yesterday
August 06, 2021
Gainers Score Media and Gaming Inc. (NASDAQ: SCR) shares climbed 79.9% to close at $32.64 on Thursday after the company, and Penn National Gaming, announced they entered into a...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
August 03, 2021
Gainers Arcturus Therapeutics (NASDAQ:ARCT) stock moved upwards by 29.05% to $44.73 during Tuesday's regular session. As of 12:35 EST, Arcturus Therapeutics's...
Via
Benzinga
Scholar Rock Announces Leadership Change
August 03, 2021
From
Scholar Rock
Via
Business Wire
Scholar Rock to Present Apitegromab TOPAZ Phase 2 Trial Results Highlighting Pharmacokinetic (PK) and Pharmacodynamic (PD) Data at the 2021 European Academy of Neurology Congress
June 18, 2021
From
Scholar Rock
Via
Business Wire
Scholar Rock Presents TOPAZ Phase 2 Data Showing the Transformative Potential of Apitegromab in Patients with Type 2 and 3 Spinal Muscular Atrophy (SMA) at the 2021 Virtual SMA Research & Clinical Care Meeting
June 11, 2021
From
Scholar Rock
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
June 09, 2021
Gainers Aethlon Medical (NASDAQ:AEMD) stock rose 248.41% to $7.7 during Wednesday's pre-market session. The market value of their outstanding shares is at $93.4...
Via
Benzinga
Scholar Rock to Present Apitegromab Clinical Data from the TOPAZ Phase 2 Trial in Patients with Type 2 and 3 Spinal Muscular Atrophy at the 2021 Virtual SMA Research & Clinical Care Meeting
June 07, 2021
From
Scholar Rock
Via
Business Wire
Scholar Rock to Present at Upcoming Healthcare Conferences in June
May 27, 2021
From
Scholar Rock
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.